The new entity, Salaera, combines multiple gas and oxygen delivery brands to support healthcare and diagnostic markets.
RT’s Three Key Takeaways:
- Strategic Consolidation: Perma Pure and Maxtec have unified under a new brand, Salaera, to form a global technology platform for breath and gas systems.
- Integrated Portfolio: The platform combines gas conditioning, oxygen analysis, and thermal-control technologies to support medical devices and environmental monitoring.
- Clinical Demand: The unification aims to address the rising need for precision in breath-based diagnostics and connected monitoring systems in hospital settings.
Perma Pure and Maxtec have unified under a new parent company, Salaera, to form a global technology platform for breath and gas systems, according to the company.
The move combines the two companies along with Bird MicroBlenders, Clayborn thermal-control technologies, and Baldwin conditioning systems. The platform is designed to serve respiratory care, diagnostics, life sciences, and air-quality monitoring markets.
The name Salaera is derived from Latin roots meaning “health carried in the air.”
“At Salaera, our vision is to redefine what’s possible in respiratory and gas technologies by harnessing innovation for global health,” said CEO Kathy Ouellette. “By uniting decades of expertise under one platform, we empower our partners to protect the integrity of every breath and foster a future where air truly carries wellness and insight for all.”
“Our new corporate structure reflects our belief that the future of human health will be shaped by what we can understand through air,” Ouellette added.
Perma Pure has specialized in gas conditioning for more than 50 years, utilizing its exclusive Nafion polymer technology. Maxtec provides oxygen analysis and delivery devices used in neonatal intensive care units (NICUs), intensive care units (ICUs), and other hospital environments.
The consolidation follows shifts in the industry where breath-based diagnostics are expanding as noninvasive sources of biomarkers for respiratory disease, metabolic conditions, and infectious pathogens, according to the news release. Additionally, clinical devices require higher precision as hospitals adopt connected monitoring systems.
The new entity works with original equipment manufacturers (OEMs) from concept to commercialization to maintain the integrity of gas pathways.
“When OEMs partner with us, they benefit from a committed engineering collaborator with over 50 years of experience,” said Megan Young, chief commercial officer. “Our advanced solutions empower partners at every stage, ensuring reliable, high-integrity breath and gas systems that truly make a difference.”
More information is available at salaera.com.
